RSV Vaccine in Pregnancy Reduces Infant Hospitalizations by 80%

A new RSV vaccine, introduced in England in 2024, has been shown to reduce infant hospitalizations by 80% when administered during pregnancy. The vaccine passes antibodies to the baby via the placenta, offering up to 85% protection when given four weeks before birth, even for premature babies.